参考文献:1. Artang R, Rome E, Nielsen JD, Vidaillet HJ (2013) Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors. Am J Cardiol 112(12):1973鈥?979. doi:10.1016/j.amjcard.2013.08.027 CrossRef 2. Clemens A, Fraessdorf M, Friedman J (2013) Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment. Vasc Health Risk Manag 9:599鈥?15. doi:10.2147/VHRM.S49830 CrossRef 3. Shavadia J, Welsh RC (2013) Acute management of ST-elevation myocardial infarction patients taking dabigatran. Can J Cardiol 29(11):1531.e13鈥?531.e14. doi:10.1016/j.cjca.2013.06.008 CrossRef 4. Vranckx P, Verheugt F, de Maat MP, Ulmans V, Regar E, Smits P, ten Berg JM, Lindeboom W, Jones R, Friedman J, Reilly P, Leebeek F (2013) A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients. EuroIntervention 8:1052鈥?060 CrossRef 5. Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van 鈥榯 Hof AW, ten Berg JM, WOEST study investigators (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381(9872):1107鈥?115 CrossRef 6. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527鈥?33 CrossRef 7. Valgimigli M, Borghesi M, Tebaldi M, Vranckx P, Parrinello G, Ferrari R, PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY Investigators (2013) Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). Eur Heart J 34(12):909鈥?19 CrossRef